The authors review available data on the benefits and risks of testosterone treatment in middle-aged and older men with moderate hypogonadism.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Peter Snyder
Testosterone Treatment and Fractures in Men with Hypogonadism
January 18, 2024 N Engl J Med 2024; 390:203-211 DOI: 10.1056/NEJMoa2308836 Abstract Testosterone treatment in men with hypogonadism improves bone density and quality, but trials with a sufficiently large sample and a sufficiently long duration to determine the effect of testosterone on the incidence of fractures are needed.
"Web Environment Integrity": Locking Down the Web
by Peter Snyder, VP of Privacy Engineering and Senior Privacy Researcher Brave strongly opposes Google’s “Web Environment Integrity” (WEI) proposal. As with many of Google’s recent changes and proposals regarding the Web, “Web Environment Integrity” would move power away from users, and toward large websites, including the websites Google itself runs.
What We Have Learned from The Testosterone Trials
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002. Content published before 2002 is available via pay-per-view purchase only.
First-Party Sets: Tearing Down Privacy Defenses Just as They're Being Built
By Peter Snyder, Sr. Director of Privacy Update (June 2, 2022): First Party Sets has been removed as a work item from the W3C’s Privacy Community Group (PrivacyCG). Because of privacy concerns like those described in this blog post (among other concerns), a majority of the browser vendors in PrivacyCG did not see a way First-Party Sets could be standardized and implemented in a privacy-respecting way.
Google's Topics API: Rebranding FLoC Without Addressing Key Privacy Issues
By Peter Snyder, Sr. Director of Privacy Google recently announced the Topics API, a revision of the earlier FLoC API. Google claims this new API addresses FLoC’s serious privacy issues. Unfortunately, it does anything but. The Topics API only touches the smallest, most minor privacy issues in FLoC, while leaving its core intact. At issue is Google’s insistence on sharing information about people’s interests and behaviors with advertisers, trackers, and others on the Web that are hostile to privacy.
Apple Security Advisory 2021-12-15-7
-----BEGIN PGP SIGNED MESSAGE----- Hash: SHA256 APPLE-SA-2021-12-15-7 Safari 15.2 Safari 15.2 addresses the following issues. Information about the security content is also available at https://support.apple.com/HT212982. WebKit Available for: macOS Big Sur and macOS Catalina Impact: Processing maliciously crafted web content may lead to arbitrary code execution Description: A buffer overflow issue was addressed with improved memory handling.
APPLE-SA-2021-12-15-5 tvOS 15.2
Full Disclosure mailing list archives By Date By Thread APPLE-SA-2021-12-15-5 tvOS 15.2 From: Apple Product Security via Fulldisclosure <fulldisclosure () seclists org> Date: Wed, 15 Dec 2021 12:58:30 -0800 -----BEGIN PGP SIGNED MESSAGE----- Hash: SHA256 APPLE-SA-2021-12-15-5 tvOS 15.2 tvOS 15.2 addresses the following issues. Information about the security content is also available at https://support.apple.com/HT212980.
Three Trends Killing Web Privacy and Decentralization Original
Oct 22, 2020 at 16:35 UTC (Ludovic Toinel/Unsplash) Three Trends Killing Web Privacy and Decentralization The World Wide Web has revolutionized human communication, but it’s under threat. We at Brave think this distributed and interlinked information system is unique among platforms for many reasons: Its design and direction aren’t controlled by any one organization. Its pages and applications are modifiable by users (e.g., extensions, ad/tracker blocking, more general browser configuration, etc).
Meta-Epidemiology of Testosterone’s Risks and Benefits—Will We Ever Know the Answer?—Reply
In Reply We disagree with Dr Haring’s statements that The Testosterone Trials (T-Trials)1- 3 had low generalizability and showed some benefits in one area and some risks in others. The goal of the T-Trials1- 3 was to determine if testosterone treatment of symptomatic older men with low testosterone would be efficacious in any way. Toward this goal, we selected only men 65 years or older who had unequivocally low testosterone values.
Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial
Question Will testosterone treatment of older men with low testosterone improve their bone density and strength? Findings Testosterone treatment of older men with low testosterone increased volumetric trabecular bone mineral density of the lumbar spine and estimated bone strength significantly compared with placebo. Meaning These results suggest that a larger and longer trial to determine whether testosterone treatment decreases fracture risk in this population is warranted.
Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial
Question Will testosterone treatment of older men with low testosterone levels and mild anemia improve their anemia? Findings Testosterone treatment of older men with low testosterone levels and unexplained anemia corrected the anemia more than placebo. This treatment also corrected anemia more than placebo in men who had anemia of known causes, such as iron deficiency. Meaning Testosterone deficiency in older men results in decreased hemoglobin levels and sometimes in mild anemia.
Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment
[Skip to Content Landing] Figure 1. Screening and Retention of Participants Throughout the Cognitive Function Trial AAMI indicates age-associated memory impairment. “Allocated to treatment incorrectly” indicates that the individuals were found to be ineligible after they received treatment allocation. aThe number analyzed is based on the primary outcome variable for the Cognitive Function Trial (delayed paragraph recall score). Figure 2.
Study Finds Testosterone Gel Is No Fountain of Youth
CHICAGO—A landmark study suggests that testosterone treatment is no fountain of youth, finding mostly modest improvement in the sex lives, walking strength and mood of a select group of older men. The long-awaited results from a rigorous, government-funded study are the first solid evidence of whether these hugely popular supplements can help treat low sex drive, lack of energy and other symptoms sometimes blamed on aging.
Global Privacy Control (GPC)
This section is non-normative. Receiving a GPC signal may have legal effects, depending on factors such as the location of the individual sending the signal, the scope of the applicable law, as well as any separate agreement between the recipient of the signal and the individual. For additional details on legal effects, consult the explainer.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Peter
Contact Peter, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack